Результаты поиска

The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed... по Paulo Vidal Campregher, Ricardo Helman, Welbert Oliveira Pereira, Renato Puga, Bianca Cristina Garcia Lisbôa, Evelyn Helena Ascendino, Mariana Yasue Saito Miyagi, Sandra Nakashima Yoshida, Isabel Bello, Michelli Silva Diniz, Guilherme Fleury Perini, Tarcila Santos Datoguia, Elvira Deolinda Rodrigues Pereira Velloso, Joao Carlos Guerra, Paulo Augusto Achucarro Silveira, Nydia Strachman Bacal, Roberta Cardoso Petroni, Juliane Musacchio, Rodrigo Santucci, Ana Fernandes Schriefer, Marco Aurélio Salvino, Rodolfo Daniel de Almeida Soares, Manuela Pinto Tibúrcio, Leila Martins Perobelli, Eizabeth Xisto Souto, Danielle Leão Cordeiro de Farias, Marcia Higashi, Adriana Valente Fadel, Carolina Kassab, Leandro Padua, Patricia W Bollman, Denise da Cunha Pasqualin, Alanna Mara Pinheiro Sobreira Bezerra, Marinus de Moraes Lima, Erika MM Costa, Vinicius R. P. Mattos, Fernando Ferreira Costa, Nelson Hamerschlak, Fábio Pires de Souza Santos

Полный текст

Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans по EM Mazur, AG Rosmarin, PA Sohl, Julia L. Newton, A Narendran

Полный текст Полный текст

Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay по L-Y Shih, Lee Ct

Полный текст Полный текст

Discriminating between essential thrombocythemia and masked polycythemia vera in <i>JAK2</i> mutated patients по Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Paola Guglielmelli, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi

Полный текст

<i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events по Alberto Álvarez‐Larrán, Beatríz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández‐Boluda, Luz Martínez‐Avilés, Concepción Fernández‐Rodríguez, Montse Gómez, Luís Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado, Carlos Besses

Полный текст Полный текст

Long term treatment of myeloproliferative disease with interferon-?-2b по Harriet S. Gilbert

Полный текст Полный текст

Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension по HS Gilbert, Vincent Praloran, E. Richard Stanley

Полный текст Полный текст

The 2008 World Health Organization classification system for myeloproliferative neoplasms по Ayalew Tefferi, Jüergen Thiele, James W. Vardiman

Полный текст Полный текст

Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders по M Okuma, Haruto Uchino

Полный текст Полный текст

Hemorrhagic Thrombocythemia; Control of Postsplenectomy Thrombocytosis with Melphalan по Thomas A. Bensinger, Gerald L. Logue, R. Wayne Rundles

Полный текст Полный текст

Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell по PJ Fialkow, GB Faguet, RJ Jacobson, K Vaidya, S Murphy

Полный текст Полный текст

The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera по Khadija Abdulkarim, Börje Ridell, Peter Johansson, Jack Kutti, Soodabeh Safai‐Kutti, Björn Andréasson

Полный текст Полный текст

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia по Gabriela M. Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, Michael Daskalakis, Bart Burington, Monic J. Stuart, David S. Snyder

Полный текст Полный текст

How common are myeloproliferative neoplasms? A systematic review and meta‐analysis по Glen J. Titmarsh, Andrew Duncombe, Mary Frances McMullin, Michael O’Rorke, Ruben A. Mesa, Frank de Vocht, Sarah Horan, Lin Fritschi, Mary Clarke, Lesley Anderson

Полный текст Полный текст

Hemorrhagic Thrombocythemia: A Critical Review по F. W. Gunz

Полный текст Полный текст

Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis по Tiziano Barbui, J. Thiele, Alessandro M. Vannucchi, Ayalew Tefferi

Полный текст Полный текст

Proinflammatory Cytokine IL‐6 and JAK‐STAT Signaling Pathway in Myeloproliferative Neoplasms по Vladan P. Čokić, Olivera Mitrović Ajtić, Bojana Beleslin‐Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac‐Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj

Полный текст Полный текст

Primary myelofibrosis: 2013 update on diagnosis, risk‐stratification, and management по Ayalew Tefferi

Полный текст Полный текст

The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis по Michael W. Deininger, Jerald P. Radich, Timothy C. Burn, Reid Huber, Dilan Paranagama, Srđan Verstovšek

Полный текст Полный текст

Detection of MPL Mutations by a Novel Allele-Specific PCR-Based Strategy по Larissa V. Furtado, Helmut C. Weigelin, Kojo S.J. Elenitoba‐Johnson, Bryan L. Betz

Полный текст